ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.

Matthew R Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.